Key Points:
Pharmaceutical Marketing Practices:
- The Department of Pharmaceuticals issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) in 2024.
- Rules for using the words “safe” and “new” for drugs were specified.
- Medical representatives should not use any inducements or subterfuge to gain an interview.
- They must not pay for access to healthcare professionals under any guise.
Engagement with Healthcare Professionals:
- Engagement for Continuing Medical Education (CME) should follow transparent guidelines.
- Conducting events in foreign locations is prohibited.
- Cash or monetary grants should not be paid to healthcare professionals or their family members.
Gifting and Benefits:
- Gifting by pharmaceutical companies or their agents is prohibited.
- No pecuniary advantage or benefit in kind can be offered to persons qualified to prescribe or supply drugs.
Compliance and Drug Promotion:
- Promotion of a drug must align with its marketing approval.
- Claims about a drug’s usefulness need to be based on up-to-date evidence.
- The word “safe” must not be used without qualification.
- It must not be claimed that a medicine has no side effects, toxic hazards, or risk of addiction.
Why in news?
The Department of Pharmaceuticals issued the Uniform Code for Pharmaceutical Marketing Practices (UCPMP), 2024.